Androgen Receptor Inhibitor class drugs

5 results

  • bicalutamide

    (Bicalutamide)
    Golden State Medical Supply, Inc.
    Bicalutamide tablets are indicated for use in combination with a luteinizing hormone-releasing hormone (LHRH) analog to treat Stage D2 metastatic carcinoma of the prostate. The 150 mg dose is not approved for standalone use or with other treatments.
    Medication Details
    Drug Interactions

  • nilandron

    (Nilutamide)
    Concordia Pharmaceuticals Inc.
    NILANDRON tablets are indicated for use in combination with surgical castration to treat metastatic prostate cancer (Stage D2). Treatment should start on the same day or the day after surgical castration for optimal effectiveness.
    Medication Details
    Drug Interactions

  • nilutamide

    (Nilutamide)
    Prasco Laboratories
    Nilutamide tablets are indicated for use alongside surgical castration to treat metastatic prostate cancer (Stage D2). For optimal effectiveness, treatment with Nilutamide should start on the same day as or the day after the surgical procedure.
    Medication Details
    Drug Interactions

  • xtandi

    (enzalutamide)
    Astellas Pharma US, Inc.
    XTANDI® is indicated for the treatment of patients with castration-resistant prostate cancer (CRPC), metastatic castration-sensitive prostate cancer (mCSPC), and non-metastatic castration-sensitive prostate cancer (nmCSPC) experiencing high-risk biochemical recurrence (high-risk BCR).
    Medication Details
    Drug Interactions